Guidant’s Last Quarter On Its Own A Downer, But ICD Business Is Rebounding
This article was originally published in The Gray Sheet
Executive Summary
Guidant's belatedly released first quarter sales were down 6% compared to the same period last year, but the firm's results signal a recovery